UNIV CANBERRA has a total of 65 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CARITAS ST ELIZABETHS BOSTON, LINK GENOMICS INC and ST ELIZABETH S MEDICAL CT OF B.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 14 | |
#2 | United States | 12 | |
#3 | China | 8 | |
#4 | Canada | 7 | |
#5 | EPO (European Patent Office) | 7 | |
#6 | Singapore | 7 | |
#7 | Australia | 4 | |
#8 | Japan | 2 | |
#9 | Taiwan | 2 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Basic materials chemistry | |
#6 | Machines | |
#7 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes | |
#6 | Peptides | |
#7 | Enzymes | |
#8 | Preservation of human bodies | |
#9 | Unspecified technologies | |
#10 | Hinges for doors or windows |
# | Name | Total Patents |
---|---|---|
#1 | Rao Sudha | 38 |
#2 | Zafar Anjum | 19 |
#3 | Milburn Peter | 13 |
#4 | Ashby Regan | 8 |
#5 | Ashby Regan Scott | 7 |
#6 | Thomas Jackson | 5 |
#7 | Kyd Jannelle | 2 |
#8 | Cripps Allan William | 2 |
#9 | Clancy Robert L | 2 |
#10 | Lobigs Mario | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020087134A1 | Beehive frame piece and beehive frame | |
AU2019338938A1 | Methods of inhibition | |
CN111936509A | Protein molecules and uses thereof | |
WO2019136532A1 | Agents and methods for predicting response to therapy | |
CN111655247A | Enhancing T cell function and treating T cell dysfunction disorders with a combination of a LSD inhibitor and a PD1 binding antagonist | |
CN110312522A | - 1 inhibitor of lysine specific histone demethylation enzyme and application thereof | |
AU2017282156A1 | Anti-parasitic compositions and methods | |
SG11201808713YA | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
SG11201701237QA | Compositions for modulating cancer stem cells and uses therefor | |
US2016354367A1 | Stem cell modulation II | |
US2016143938A1 | Methods and compositions for modulating cancer stem cells | |
AU2013203696A1 | Recombinant Viral Vectors and Uses Therefor |